Daiana L. Aguero

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Effects of Siltuximab Versus Corticosteroids in Preventing COVID-19 Pneumonia Disease Progression: Multicentre, Open-Label, Randomized Clinical Trial.

Effects of Siltuximab Versus Corticosteroids in Preventing COVID-19 Pneumonia Disease Progression: Multicentre, Open-Label, Randomized Clinical Trial.

Journal: Clinical and translational science

Published: July 01, 2025

OAS1 and OAS3 genetic variants enhance inflammatory responses to SARS-CoV-2.

OAS1 and OAS3 genetic variants enhance inflammatory responses to SARS-CoV-2.

Journal: iScience

Published: July 22, 2024

Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study.

Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study.

Journal: Infectious diseases and therapy

Published: December 29, 2021

C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19.

C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19.

Journal: Scientific reports

Published: September 08, 2021

Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients.

Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients.

Journal: Infection

Published: September 03, 2021

Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia: a prospective study.

Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia: a prospective study.

Journal: BMJ open

Published: August 18, 2021

Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19.

Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19.

Journal: The Journal of antimicrobial chemotherapy

Published: May 22, 2021

Experience with the use of siltuximab in patients with SARS-CoV-2 infection.

Experience with the use of siltuximab in patients with SARS-CoV-2 infection.

Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

Published: May 13, 2021

Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection.

Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection.

Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

Published: April 08, 2021

Real-life use of remdesivir in hospitalized patients with COVID-19.

Real-life use of remdesivir in hospitalized patients with COVID-19.

Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

Published: March 06, 2021

Impact of Inflammatory Response Modifiers on the Incidence of Hospital-Acquired Infections in Patients with COVID-19.

Impact of Inflammatory Response Modifiers on the Incidence of Hospital-Acquired Infections in Patients with COVID-19.

Journal: Infectious diseases and therapy

Published: February 24, 2021

Mycobacterium Wolinskyi: A New Non-Tuberculous Mycobacterium Associated with Cardiovascular Infections?

Mycobacterium Wolinskyi: A New Non-Tuberculous Mycobacterium Associated with Cardiovascular Infections?

Journal: Infectious diseases and therapy

Published: December 29, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026